Advertisement

The Scientist

» FDA

Most Recent

image: 23andMe Steps Back

23andMe Steps Back

By | December 6, 2013

The company announces that it will stop offering health interpretations of personal genetic data.

4 Comments

image: 23andMe Now Facing Lawsuit

23andMe Now Facing Lawsuit

By | December 4, 2013

Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.

8 Comments

image: FDA Approves NGS Tests

FDA Approves NGS Tests

By | November 21, 2013

The agency has cleared marketing of four next-generation sequencing devices from Illumina.

0 Comments

image: A Hair-Raising Solution?

A Hair-Raising Solution?

By | September 1, 2013

In the long-fought battle against baldness, researchers are finally identifying molecular pathways that can be manipulated to generate new hair follicles.

1 Comment

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

image: The Elixir Tragedy, 1937

The Elixir Tragedy, 1937

By | June 1, 2013

A mass poisoning of 105 patients treated with an untested medication spurred Congress to empower the US Food and Drug Administration to monitor drug safety.

2 Comments

image: FDA to Regulate Fecal Transplants

FDA to Regulate Fecal Transplants

By | May 21, 2013

From now on, US physicians and researchers will have to get approval from the FDA before they can perform a stool transplant.

0 Comments

image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
Advertisement
Life Technologies